Hartenstein R, Ertl E, Possinger K, Ehrhart H
Klin Wochenschr. 1979 Nov 2;57(21):1191-3. doi: 10.1007/BF01491760.
Four patients, who suffered from malignant, disseminated tumors but had a morphologically intact bone marrow, where given a peroral Hydroxyurea (HU) infusion in a concentration of about 5 x 10(-4) mol over a period of 10 h. As indicator of the DNA synthesis the 3H-TdR-incorporation of bone marrow, gained by puncture before, during, and/or after HU application, was measured. While using HU, the DNA synthesis was extensively inhibited. Fourteen to 16 h after discontinuing the HU it increased by the factor 1.5 to 2 of the initial value, i.e., before treatment. This is interpreted as a partial synchronization of bone marrow cells where effects of cell depletion and recruitment are not to be entirely excluded, Toxicity, such as the decrease of peripheral blood cells or nausea, did not occur.
四名患有恶性弥漫性肿瘤但骨髓形态完整的患者,在10小时内接受了浓度约为5×10⁻⁴摩尔的口服羟基脲(HU)输注。通过在HU应用前、应用期间和/或应用后穿刺获取骨髓,测量3H-TdR掺入量作为DNA合成的指标。使用HU时,DNA合成受到广泛抑制。停用HU后14至16小时,其增加至初始值(即治疗前)的1.5至2倍。这被解释为骨髓细胞的部分同步化,其中细胞耗竭和补充的影响不能完全排除,未出现外周血细胞减少或恶心等毒性反应。